Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
暂无分享,去创建一个
P. Herrlich | P. Angel | F. Weih | J. Tuckermann | G. Schütz | H. Reichardt | M. Göttlicher | M. Vujić
[1] P. Herrlich. Cross-talk between glucocorticoid receptor and AP-1 , 2001, Oncogene.
[2] K. Yamamoto,et al. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.
[3] K. H. Richter,et al. The DNA Binding-Independent Function of the Glucocorticoid Receptor Mediates Repression of Ap-1–Dependent Genes in Skin , 1999, The Journal of cell biology.
[4] P. Barnes,et al. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.
[5] M. Karin. New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable? , 1998, Cell.
[6] K. Kaestner,et al. DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival , 1998, Cell.
[7] T. Wilckens,et al. Glucocorticoids and immune function: unknown dimensions and new frontiers. , 1997, Immunology today.
[8] P. Herrlich,et al. IκBα‐independent downregulation of NF‐κB activity by glucocorticoid receptor , 1997, The EMBO journal.
[9] J. Anrather,et al. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. , 1997, Journal of immunology.
[10] B. Groner,et al. Functional interactions between Stat5 and the glucocorticoid receptor , 1996, Nature.
[11] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[12] Miguel Beato,et al. Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.
[13] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[14] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[15] J. J. Moreno,et al. Effects of an anti-inflammatory peptide (antiflammin 2) on cell influx, eicosanoid biosynthesis and oedema formation by arachidonic acid and tetradecanoyl phorbol dermal application. , 1995, Biochemical pharmacology.
[16] J A Gustafsson,et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.
[17] P. Angel,et al. The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. , 1995, Chemical senses.
[18] M. Karin,et al. Glucocorticoid‐induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. , 1995, The EMBO journal.
[19] P. Herrlich,et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP‐1. , 1994, The EMBO journal.
[20] T. Wirth,et al. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation , 1993, Nature.
[21] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[22] K. Yamamoto,et al. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.
[23] S. Zuckerman,et al. Differential regulation of lipopolysaccharide‐induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary‐adrenal axis , 1989, European journal of immunology.
[24] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[25] F. Marks,et al. The mouse ear edema: a quantitatively evaluable assay for tumor promoting compounds and for inhibitors of tumor promotion. , 1984, Cancer letters.
[26] U. Mohr,et al. The carcinogenic effect of 1,1-diethyl-3-methyl-3-nitrosourea in Syrian golden hamsters. , 1984, Cancer letters.